Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

被引:66
|
作者
Bradley, Walter G. [1 ]
Borenstein, Amy R. [2 ]
Nelson, Lorene M. [3 ]
Codd, Geoffrey A. [4 ]
Rosen, Barry H. [5 ]
Stommel, Elijah W. [6 ]
Cox, Paul Alan [7 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
[2] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA
[3] Stanford Univ, Sch Med, Dept Hlth & Res Policy, Palo Alto, CA 94304 USA
[4] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland
[5] US Geol Survey, Off Reg Execut, Orlando, FL USA
[6] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH USA
[7] Inst Ethnomed, Jackson, WY USA
关键词
Amyotrophic lateral sclerosis; BMAA; cyanobacteria; epidemiology; environmental toxicants; METHYLAMINO-L-ALANINE; SCLEROSIS/PARKINSONISM-DEMENTIA COMPLEX; TRANSFER-RNA SYNTHETASE; MOTOR-NEURON DISEASE; PARKINSONISM-DEMENTIA; AMINO-ACID; TOXIC CYANOBACTERIA; CHAMORRO PEOPLE; NEUROTOXIN BMAA; GUAM;
D O I
10.3109/21678421.2012.750364
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is a broad scientific consensus that amyotrophic lateral sclerosis (ALS) is caused by gene-environment interactions. Mutations in genes underlying familial ALS (fALS) have been discovered in only 5-10% of the total population of ALS patients. Relatively little attention has been paid to environmental and lifestyle factors that may trigger the cascade of motor neuron death leading to the syndrome of ALS, although exposure to chemicals including lead and pesticides, and to agricultural environments, smoking, certain sports, and trauma have all been identified with an increased risk of ALS. There is a need for research to quantify the relative roles of each of the identified risk factors for ALS. Recent evidence has strengthened the theory that chronic environmental exposure to the neurotoxic amino acid beta-N-methylamino-L-alanine (BMAA) produced by cyanobacteria may be an environmental risk factor for ALS. Here we describe methods that may be used to assess exposure to cyanobacteria, and hence potentially to BMAA, namely an epidemiologic questionnaire and direct and indirect methods for estimating the cyanobacterial load in ecosystems. Rigorous epidemiologic studies could determine the risks associated with exposure to cyanobacteria, and if combined with genetic analysis of ALS cases and controls could reveal etiologically important gene-environment interactions in genetically vulnerable individuals.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [21] The Role of Environmental Toxins in Amyotrophic Lateral Sclerosis Risk
    Cragg, Jacquelyn J.
    Cudkowicz, Merit E.
    Weisskopf, Marc G.
    JAMA NEUROLOGY, 2016, 73 (07) : 779 - 780
  • [22] Novel therapeutic targets in neurodegenerative diseases: Lessons from amyotrophic lateral sclerosis
    Stanley H. Appel
    David R. Beers
    Jenny S. Henkel
    Weihua Zhao
    Current Neurology and Neuroscience Reports, 2008, 8 : 353 - 355
  • [23] Novel therapeutic targets in neurodegenerative diseases: Lessons from amyotrophic lateral sclerosis
    Appel, Stanley H.
    Beers, David R.
    Henkel, Jenny S.
    Zhao, Weihua
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2008, 8 (05) : 353 - 355
  • [24] Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
    Mosley, R. Lee
    Gendelman, Howard E.
    EXPERIMENTAL NEUROLOGY, 2010, 222 (01) : 1 - 5
  • [25] Environmental exposure to pesticides and Amyotrophic Lateral Sclerosis in the South of Spain
    Fuenmayora, S. Bermudo
    Castrob, P. J. Serrano
    Subiranac, P. Quiroga
    Palmerod, S. Lopez
    Mullore, M. Requena
    Carreno, T. Parron
    NEUROLOGIA, 2023, 38 (07): : 447 - 452
  • [26] Amyotrophic lateral sclerosis - a multisystem neurodegenerative disorder
    Grossman, Murray
    NATURE REVIEWS NEUROLOGY, 2019, 15 (01) : 5 - 6
  • [27] Amyotrophic lateral sclerosis: An emblematic neurodegenerative disease
    Viader, F.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (03): : 272 - 286
  • [28] Amyotrophic lateral sclerosis — a multisystem neurodegenerative disorder
    Murray Grossman
    Nature Reviews Neurology, 2019, 15 : 5 - 6
  • [29] Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
    Tumer, Martin R.
    Goldacre, Raph
    Talbot, Kevin
    Goldacre, Michael J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (03): : 244 - 246
  • [30] TNF inhibitors and amyotrophic lateral sclerosis: a risk factor?
    Petitpain, N.
    Devos, D.
    Bagheri, H.
    Rocher, F.
    Masmoudi, K.
    Coquerel, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 43 - 43